AbbVie has appointed Kelly Sanderson Schrems as Vice President and General Manager, UK. Sanderson Schrems succeeds Steve ...

Boehringer Ingelheim and Immunitas Therapeutics have announced a global licensing agreement for a preclinical antibody programme being developed for chronic inflammatory and autoimmune diseases.

Mental health providers revealed years ago what healthcare is only now beginning to recognise: information alone does not ...

Amgen and UCB’s novel osteoporosis treatment Evenity has been approved by the FDA, nearly two years after it was first submitted. Evenity (romosozumab) is a first-in-class antibody treatment that ...

The energy is building as we prepare to head to New Orleans, LA, for the annual scientific sessions of the American Diabetes ...

Novartis has started construction on its new 46,000 sq. ft radioligand therapy (RLT) manufacturing site in Denton, Texas, the ...

OVID Health has appointed Davide Scalenghe as Head of Global Strategy & Partnerships. In his new role, Scalenghe will focus ...

Inizio, the global commercialization partner to the health and life sciences industry, today announced the launch of ...

Cue Biopharma has appointed Shao-Lee Lin as CEO, President and Director. Lin will succeed Lucinda Warren, Interim President ...

LEO Pharma has announces that it will acquire Replay, a gene therapy company focused on developing transformative treatments ...

Eli Lilly has announced an additional investment of $4.5bn across two of its three sites in Indiana in the US, bringing the ...